DUBLIN--(BUSINESS WIRE)--The "Latin America Cell Culture Market: Focus on Product Types (Consumables and Instruments), End Users, Country Data (5 Countries), and Competitive Landscape: Analysis and Forecast, 2018-2025" report has been added to ResearchAndMarkets.com's offering.
The Latin America cell culture market has been witnessing a steady growth. The market is expected to continue to grow with a single digit CAGR of 6.2% during the forecast period, 2018-2025. Growing at the fastest CAGR of 6.48% during the forecast period of 2018-2025, the consumables segment is anticipated to generate a value of $811.5 million in 2025.
Although a mature market, the cell culture market is consistently witnessing significant evolution in the technological developments it has given rise to. With respect to organ transplantation and study of the disease mechanism in human, the concept of 3D cell culture has defined the current era. This type of cell culture not only allows for better visualization of the environment within the human body, but there is also the aspect of realizing the instantaneous effects of a wide variety of agents in real-time.
Another largely undermined factor for the rising global disease burden is antimicrobial resistance (AMR). Largely a natural phenomenon, antimicrobial resistance is triggered by the excess usage of antibiotics for the treatment of diseases with microbial origins. A complex issue of global concern, AMR is majorly driven by human action and perverse incentives. AMR has been synonymous with the promotion of drug discovery and novel molecule discovery.
The predominant aspect of cell culture is integral for any biopharmaceutical manufacturing process. Also, cell culture plays an integral role in the cultivation of artificial organs, for the development of cells to test antibiotics against, and for research purposes that delve deep into the understanding of the effect of disease-causing organisms within the human body.
With the Latin America region posing as one of the lesser-developed regions with respect to the medical advancements that have become routine in other parts of the world, there is immense potential for growth of the Latin America cell culture market.
Study Coverage
The purpose of the study is to gain a holistic view of the Latin America cell culture market in terms of various factors, such as recent trends and product advancements, influencing the market.
The scope of this report is centered upon conducting a detailed study of the products allied with the Latin America cell culture market, broadly classified as consumables and instruments. However, the market estimation only comprises manufacturers of these products.
The Latin America cell culture market is segmented into three different segments namely product, end user, and country. These segments are further segmented into several sub-segments to ease the market estimation and to gain a holistic view of the market. The overall market value was estimated using different approaches and validated with each other.
Based on countries, the Latin America cell culture market is segmented into Brazil, Mexico, Argentina, Chile, and Colombia, which have been studied and documented in detail to understand the various factors that are consistently responsible for shaping up the market.
The key manufacturers who have been contributing significantly to the Latin America cell culture market include Becton, Dickinson and Company, CellGenix GmbH, Corning Incorporated, Eppendorf AG, Fujifilm Holdings Corporation, General Electric Company, Lonza Group AG, Merck KGaA, Sartorius AG, and Thermo Fisher Scientific Inc., among others.
Key Topics Covered
Executive Summary
1 Market Overview
1.1 Cell Culture Technology
1.2 Historical Perspective of Cell Culture
1.3 Classification of Latin America Cell Culture Market
1.4 Market Footprint
1.5 Future Potential of the Latin America Cell Culture Market
2 Market Dynamics
2.1 Overview
2.2 Iceberg Analysis
2.3 Impact Analysis
2.4 Market Drivers
2.4.1 Increasing Incidence of Infectious Diseases Pressurizes Increasing Drug Discovery
2.4.2 Growing Demand for Monoclonal Antibodies (mAbs)
2.4.3 Growing Availability of Advanced Media Solutions
2.4.4 Increasing Government-funding for Cell-based Research
2.5 Market Restraints
2.5.1 Concerns for Scalability of Process
2.5.2 Ethical Concerns in the Production of Cell Culture Media
2.5.3 Lack of Skilled Personnel for Proper Handling of Culture Media
2.6 Market Opportunities
2.6.1 Insurgence of 3D Cell Cultures
2.6.2 Escalating Cases of Severe Chronic Diseases that Require Organ Transplantation
3 Competitive Landscape
3.1 Key Strategies and Developments
3.1.1 Product Launches and Enhancements
3.1.2 Synergistic Activities
3.1.3 Acquisitions, Approvals, and Expansion Activities
3.2 Market Share Analysis
3.3 Growth Share Analysis (Opportunity Mapping)
3.4 Industry Attractiveness
4 Latin America Cell Culture Market (by Product)
4.1 Overview
4.2 Consumables
4.2.1 Cell Culture Reagents and Supplements
4.2.2 Media
4.2.3 Sera
4.2.4 Plastic and Glass Consumables
4.3 Instruments
5 Latin America Cell Culture Market (by End User)
5.1 Overview
5.2 Biotechnology and Life-Sciences Companies
5.3 Pharmaceutical Companies
5.4 Academic and Research Institutes
6 Latin America Cell Culture Market (by Country)
6.1 Overview
6.2 Brazil
6.3 Mexico
6.4 Argentina
6.5 Chile
6.6 Colombia
6.7 Rest-of-Latin America
7 Company Profiles
7.1 Overview
7.2 Becton, Dickinson and Company
7.2.1 Company Overview
7.2.2 Role of Becton, Dickinson and Company in the Latin America Cell Culture Market
7.2.3 Financials
7.2.4 Key Insights about Financial Health of the Company
7.2.5 SWOT Analysis
7.3 CellGenix GmbH
7.4 Corning Incorporated
7.5 Eppendorf AG
7.6 Fujifilm Holdings Corporation
7.7 General Electric Company
7.8 Lonza Group AG
7.9 Merck KGaA
7.10 Sartorius AG
7.11 Thermo Fisher Scientific Inc.
8 Research Scope and Methodology
8.1 Report Scope
8.2 Latin America Cell Culture Market: Research Methodology
For more information about this report visit https://www.researchandmarkets.com/research/vrccmg/latin_america?w=4
